×
Entrez Id:
348
Gene Symbol:
APOE
APOE
0.200
Biomarker
disease
BEFREE
APOE genotyping was performed in patients with probable Alzheimer's disease (AD) (n=504), frontotemporal dementia (FTD) (n=47), vascular dementia (VaD) (n=152), mixed dementia (n=132), mild cognitive impairment (MCI) (n=44), Parkinson's disease (PD) (n=30), dementia with Lewy bodies (DLB ) (n=17), and multisystem atrophy (MSA)/progressive supranuclear palsy (PSP) (n=12).
12876259
2003
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
alpha-Synuclein aggregation and toxicity play a major role in Parkinson's disease and dementia with Lewy bodies .
15522241
2004
×
Entrez Id:
3308
Gene Symbol:
HSPA4
HSPA4
0.020
AlteredExpression
disease
BEFREE
HSP70 mRNA was increased in DLB , whereas the mRNAs for HSP90 and HDJ1 were unchanged.
16319716
2005
×
Entrez Id:
6667
Gene Symbol:
SP1
SP1
0.010
AlteredExpression
disease
BEFREE
Sp1 transcription factor expression was examined by immunohistochemistry, immunofluorescence and confocal microscopy in Alzheimer disease (AD), Pick disease (PiD), progressive supranuclear palsy (PSP), Parkinson disease (PD) and Dementia with Lewy bodies (DLB ).
16378688
2006
×
Entrez Id:
120892
Gene Symbol:
LRRK2
LRRK2
0.100
GeneticVariation
disease
BEFREE
Lrrk2 G2019S was observed in approximately 2% (n = 8) of our Parkinson's disease/Lewy body disease cases (n = 405).
16437559
2006
×
Entrez Id:
120892
Gene Symbol:
LRRK2
LRRK2
0.100
Biomarker
disease
LHGDN
Lrrk2 G2019S was observed in approximately 2% (n = 8) of our Parkinson's disease/Lewy body disease cases (n = 405).
16437559
2006
×
Entrez Id:
9627
Gene Symbol:
SNCAIP
SNCAIP
0.030
Biomarker
disease
BEFREE
Synphilin -1A is present in Lewy bodies of patients with Parkinson's disease and Diffuse Lewy Body disease , and is observed in detergent-insoluble fractions of brain protein samples obtained from Diffuse Lewy Body disease patients.
16595633
2006
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
Alpha-synuclein mutations are much less frequent, but the importance of alpha-synuclein has been confirmed by the demonstration of alpha-synuclein deposition as Lewy bodies in patients with PD and Lewy body dementia .
17563248
2007
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
alpha-Synuclein (alpha-syn) is the major component of pathologic inclusions that characterize neurodegenerative disorders such as Parkinson disease, dementia with Lewy body disease , and multiple system atrophy.
18451726
2008
×
Entrez Id:
120892
Gene Symbol:
LRRK2
LRRK2
0.100
Biomarker
disease
BEFREE
Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease .
19878656
2009
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
Alpha-synuclein (alpha-syn) aggregation is a neuropathological hallmark of many diseases including Dementia with Lewy Bodies (DLB ) and Parkinson's Disease (PD), collectively termed the alpha-synucleinopathies.
19944097
2010
×
Entrez Id:
6696
Gene Symbol:
SPP1
SPP1
0.020
GeneticVariation
disease
BEFREE
Osteopontin single-nucleotide polymorphism-66 is associated with Lewy body disease and considered a susceptibility factor.
21469198
2011
×
Entrez Id:
2629
Gene Symbol:
GBA
GBA
0.500
GeneticVariation
disease
BEFREE
Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.
21472771
2011
×
Entrez Id:
2630
Gene Symbol:
GBAP1
GBAP1
0.060
GeneticVariation
disease
BEFREE
Acid β-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter α-synuclein processing.
21472771
2011
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
α-Synuclein dysfunction is the critical pathogenic event in Parkinson's disease, multiple system atrophy and dementia with Lewy bodies .
21863007
2011
×
Entrez Id:
9627
Gene Symbol:
SNCAIP
SNCAIP
0.030
Biomarker
disease
BEFREE
Synphilin-1 -binding protein NUB1 is colocalized with nonfibrillar, proteinase K-resistant α-synuclein in presynapses in Lewy body disease .
21937912
2011
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
PosttranslationalModification
disease
BEFREE
α-Synuclein is causative for autosomal dominant familial Parkinson disease and dementia with Lewy bodies , and the phosphorylation of α-synuclein at residue Ser-129 is a key posttranslational modification detected in Parkinson disease/dementia with Lewy bodies lesions.
22232559
2012
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
α-Synuclein has been reported to be important in modulating brain plasticity and to be a key protein in neurodegenerative diseases, including Lewy body dementia (LBD).
23175842
2012
×
Entrez Id:
2629
Gene Symbol:
GBA
GBA
0.500
GeneticVariation
disease
BEFREE
GBA1 mutations have been implicated in Lewy body diseases (LBDs), such as Parkinson's disease and dementia with Lewy bodies .
23435096
2013
×
Entrez Id:
2896
Gene Symbol:
GRN
GRN
0.030
GeneticVariation
disease
BEFREE
GRN Thr272fs clinical heterogeneity: a case with atypical late onset presenting with a dementia with Lewy bodies phenotype.
23478307
2013
×
Entrez Id:
2896
Gene Symbol:
GRN
GRN
0.030
AlteredExpression
disease
BEFREE
Progranulin plasma levels were analyzed in a variety of FTLD phenotypes (n = 71), dementia of the Alzheimer type (DAT) (n = 22) and probable Lewy body dementia (n = 8), both latter groups presented with asymmetric perisylvian atrophy.
23724906
2013
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
α-Synuclein aggregation in neurons is a well-characterized feature of Parkinson's disease and dementia with Lewy bodies .
24502382
2014
×
Entrez Id:
7422
Gene Symbol:
VEGFA
VEGFA
0.010
AlteredExpression
disease
BEFREE
VEGF and FVIIIRA levels were, however, significantly lower in DLB .
24521289
2014
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
Alpha-synuclein is a key protein in Parkinson disease (PD) and dementia with Lewy bodies .
25383638
2014
×
Entrez Id:
6622
Gene Symbol:
SNCA
SNCA
0.800
Biomarker
disease
BEFREE
Alpha-synuclein (αSyn ) plays a central role in the pathogenesis of Parkinson's disease (PD) and dementia with Lewy bodies (DLB ).
26362253
2015